Nimesulide + Serratiopeptidase Tablet Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 100mg +10mg
Reference Brands: Nise Plus(India)
Category:
Analgesic
Nimesulide + Serratiopeptidase is a combination of two medicines: Nimesulide and Serratiopeptidase which relieve pain.
Nimesulide + Serratiopeptidase Tablet is available in Tablets
and strengths such as 100mg +10mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Nimesulide + Serratiopeptidase Tablet is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Nimesulide + Serratiopeptidase Tablet can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Nimesulide + Serratiopeptidase tablets are regulated in the EU and US, with dossiers demonstrating safety, efficacy, and manufacturing quality compliant with GMP standards. In the US, FDA approval involves clinical validation and safety assessments; however, this combination is primarily marketed in select regions. In the EU, CE marking certifies conformity with MDR standards. These formulations undergo validation, stability testing, and audits, with detailed documentation including safety profiles, clinical data, and manufacturing practices. For licensing procedures, approved dossiers, and latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe, effective combination therapies supporting anti-inflammatory and pain management across healthcare and veterinary sectors worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing